Antibody / Protein Production & Purification | Webinars
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics. Sponsored by WuXi Biologics.
Antibody fragments such as Fab, ScFv, and VHH are transforming the landscape of antibody drug development, used both as independent therapeutics and key components in bispecific antibodies. However, producing and engineering these fragments comes with unique challenges like low yields, impurities, and stability concerns. In this webinar, we’ll showcase cutting-edge solutions to these challenges, offering fresh insights into molecular engineering, high-titer CHO expression systems, and targeted purification techniques. These approaches are specifically tailored to address the unique challenges of Fab, ScFv, and VHH.
What you’ll gain from this webinar:
- Innovative methods to overcome production hurdles such as low yield, throughput limitations, and impurities.
- Advanced molecular engineering strategies to reduce aggregation and improve yield.
- Fragment-specific optimization strategies for Fab, ScFv, and VHH to maximize production efficiency and ensure higher purity.
Please fill in the form below to access this content: